Two Covid-era biotech IPOs — Spruce and Graphite Bio — see stock head in different directions

It's been an up-and-down week for Bay Area life sciences stocks as health care executives start to flow into San Francisco for the 41st annual J.P. Morgan Healthcare Conference.